Literature DB >> 26790758

Mood disturbance during experimental endotoxemia: Predictors of state anxiety as a psychological component of sickness behavior.

Julie Lasselin1, Sigrid Elsenbruch2, Mats Lekander3, John Axelsson3, Bianka Karshikoff4, Jan-Sebastian Grigoleit5, Harald Engler2, Manfred Schedlowski2, Sven Benson6.   

Abstract

Lipopolysaccharide (LPS) administration is a well-established model to assess afferent immune-to-brain communication and behavioral aspects of inflammation. Nevertheless, only few studies in comparatively small samples have assessed state anxiety as a psychological component of sickness behavior despite possible clinical implications for the pathophysiology of neuropsychiatric conditions. Thus, the goal of the present analyses carried out in a large, pooled dataset from two independent study sites was to analyze the state anxiety response to LPS administration and to investigate predictors (i.e., cytokine changes; pre-existing anxiety and depression symptoms assessed with the Hospital Anxiety and Depression Scale) of the LPS-induced state anxiety changes at different time points after LPS administration. Data from 186 healthy volunteers who participated in one of six randomized, placebo-controlled human studies involving intravenous administration of LPS at doses of 0.4-0.8ng/kg body weight were combined. State anxiety as well as circulating interleukin (IL)-6, tumor necrosis factor (TNF)-α and IL-10 concentrations were significantly increased 2h and 3h after LPS administration, with a peak at 2h, and returned to baseline 6h after administration. Greater changes in IL-6 from baseline to 3h after LPS administration significantly and independently predicted a more pronounced LPS-induced state anxiety response. In addition, higher pre-existing subclinical anxiety symptoms significantly predicted a lower increase in state anxiety 3h and 6h after LPS-administration, which was mediated by TNF-α changes. In conclusion, our findings give additional support for a putative role of inflammatory mechanisms in the pathophysiology of stress-related and anxiety disorders and give new insight on the potential role of pre-existing subclinical affective symptoms.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Cytokines; HADS; Inflammation; Interleukin-6; Lipopolysaccharide; Predictor variables; Psychological condition; STAI; Sickness behavior

Mesh:

Substances:

Year:  2016        PMID: 26790758     DOI: 10.1016/j.bbi.2016.01.003

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  24 in total

1.  Unpredictable Chronic Mild Stress Paradigm Established Effects of Pro- and Anti-inflammatory Cytokine on Neurodegeneration-Linked Depressive States in Hamsters with Brain Endothelial Damages.

Authors:  Ennio Avolio; Gilda Fazzari; Maria Mele; Raffaella Alò; Merylin Zizza; Wei Jiao; Anna Di Vito; Tullio Barni; Maurizio Mandalà; Marcello Canonaco
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

Review 2.  Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety.

Authors:  Mandakh Bekhbat; Gretchen N Neigh
Journal:  Brain Behav Immun       Date:  2017-02-16       Impact factor: 7.217

3.  Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms.

Authors:  H Engler; P Brendt; J Wischermann; A Wegner; R Röhling; T Schoemberg; U Meyer; R Gold; J Peters; S Benson; M Schedlowski
Journal:  Mol Psychiatry       Date:  2017-01-31       Impact factor: 15.992

4.  Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression.

Authors:  Bruce R Stevens; Ruby Goel; Kim Seungbum; Elaine M Richards; Richard C Holbert; Carl J Pepine; Mohan K Raizada
Journal:  Gut       Date:  2017-08-16       Impact factor: 23.059

5.  Inflammation negatively correlates with amygdala-ventromedial prefrontal functional connectivity in association with anxiety in patients with depression: Preliminary results.

Authors:  Neeti D Mehta; Ebrahim Haroon; Xiaodan Xu; Bobbi J Woolwine; Zhihao Li; Jennifer C Felger
Journal:  Brain Behav Immun       Date:  2018-08-01       Impact factor: 7.217

6.  Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial.

Authors:  Julie Lasselin; Michael T Treadway; Tamara E Lacourt; Anne Soop; Mats J Olsson; Bianka Karshikoff; Sofie Paues-Göranson; John Axelsson; Robert Dantzer; Mats Lekander
Journal:  Neuropsychopharmacology       Date:  2016-09-13       Impact factor: 7.853

7.  Neuroimmune modulation of pain across the developmental spectrum.

Authors:  Bianka Karshikoff; Melissa Anne Tadros; Sean Mackey; Ihssane Zouikr
Journal:  Curr Opin Behav Sci       Date:  2019-03-19

Review 8.  The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation.

Authors:  Larissa N Dooley; Kate R Kuhlman; Theodore F Robles; Naomi I Eisenberger; Michelle G Craske; Julienne E Bower
Journal:  Neurosci Biobehav Rev       Date:  2018-09-07       Impact factor: 8.989

9.  Prevalence and risk factors for post-traumatic stress, anxiety, and depression in sepsis survivors after ICU discharge.

Authors:  Allan J Calsavara; Priscila A Costa; Vandack Nobre; Antonio L Teixeira
Journal:  Braz J Psychiatry       Date:  2020-10-07       Impact factor: 2.697

Review 10.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.